Company Filing History:
Years Active: 2018
Title: Innovations of Sung-Bae Lee in Pharmaceutical Synthesis
Introduction
Sung-Bae Lee is a notable inventor based in Yangju-si, South Korea. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of methods that enhance the purity and yield of important medicinal compounds.
Latest Patents
Sung-Bae Lee holds a patent for a synthesis method aimed at improving tenofovir disoproxil fumarate (Teno-DF). This compound is crucial in the treatment of hepatitis B and HIV due to its bioactive properties. The patented method utilizes an ion-exchange resin, specifically Dowex 50W in hydrogen form, to prevent the formation of impurities and byproducts during synthesis. Additionally, the invention includes a method for preparing an oral dissolving film dosage form using the high-purity tenofovir compound as an effective ingredient.
Career Highlights
Sung-Bae Lee is associated with Firson, where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficiency and effectiveness of drug formulations, contributing to advancements in medical treatments.
Collaborations
He collaborates with notable colleagues, including Dong-Jin Kim and Chang-Hui Koo, who share his commitment to improving pharmaceutical processes.
Conclusion
Sung-Bae Lee's innovative work in the synthesis of tenofovir disoproxil fumarate exemplifies the importance of advancements in pharmaceutical technology. His contributions are vital for the development of effective treatments for serious health conditions.